Welcome to the first installment of the SRS NUTRI-KNOW, where we find the heart of health and nutrition, exploring the benefits and science behind our products. Today, we shine the spotlight on D-Mannose, a monosaccharide with promising benefits for urinary tract health.
Urinary Tract Infections (UTIs) are among the most common bacterial infections globally, affecting more than 150 million people annually. These infections are especially prevalent among women, with around 50% experiencing at least one UTI episode in their lifetime. However, D-Mannose emerges as a beacon of hope. Often compared to the well-known cranberry for its benefits, D-Mannose is not merely for women but also beneficial to men, pets, and even in sports nutrition.
Research indicates that D-Mannose could be a viable alternative or complementary remedy for UTIs, particularly as a preventive measure against recurrent UTIs. When excreted in urine, it potentially impedes Escherichia coli—the primary culprit behind UTIs—from adhering to the bladder's lining and initiating infection.
The Market Outlook
The demand for D-Mannose is not just a fleeting trend. By 2024, the global D-Mannose market is projected to hit the $1.3 billion mark, advancing at a 2.9% CAGR through 2034. Its versatility spanning genders, pets, and various nutrition segments only underscores its growing market potential.
In High Demand: Preferred Specifications
• 30 Mesh Powder: The go-to choice for most, this powder is ideal for capsules and tablets with a bulk density of 0.30~0.50g/ml.
• 80 Mesh Powder: Best suited for liquids due to its granulation properties, which allow for uniform granules and reduced machine wear.
• 20 Mesh Granules: With a bulk density of 0.55~0.75g/ml, these granules are another popular option.
Stay tuned for our next post, where we'll delve into the innovative bio-based process behind D-Mannose manufacturing—setting a new standard for natural, effective health solutions.
#UTIHealth #NutriSeries #Dmannose #HealthcareInnovation #Wellness
For more products or information,
Post time: Jun-11-2024
